Cholamandalam Investment | Brokerage firm Axis Securities expects Cholamandalam to be one of the biggest winners in 2025 as its price target of ₹1,675, implies a potential upside of 41% from current levels. The stock had declined 6% in 2024.
Prestige Estates | The Nifty Realty index had another positive year in 2024 and Prestige Estates featured among the top performers there, with gains of 44%. Axis Securities expects further upside on the stock as its price target of ₹2,195 implies a potential upside of 30% from current levels.
Gravita India | The stock doubled in 2024. It is also embarking on some expansion plans and Axis Securities expects that to flow into returns as well. The brokerage sees another 38% upside for the stock as it sees Gravita touching levels of ₹3,000 in 2025.
J Kumar Infra | The infrastructure company, known mainly for projects in and around Mumbai, gained close to 33% in 2024 and Axis Securities expects healthy returns in 2025 as well. It has a price target of ₹950 on the stock, implying a potential upside of 25% for the year.
HUDCO | Bajaj Broking said that tailwinds are emerging for HUDCO from the recent PMAY-2 scheme, which will translate into disbursements worth ₹75,000 crore to ₹1 lakh crore in the next three years, along with robust urban infra financing opportunities from NHAI projects announced by states. Incremental loan mix tilting towards high growth, high yielding urban infra assets is another positive. On the charts, HUDCO has generated a breakout above the falling channel, signalling resumption of the upmove and offers a fresh entry opportunity. Bajaj Broking recommends buying the stock between the ₹238 – ₹249 range for a price target of ₹314 in the next 12 months, which implies a potential upside of 29%.
Laurus Labs | Laurus Labs is showing signs of a potential turnaround. It expects the second half of the year to be driven by a strong order book and the delivery of anticipated projects. On the charts, the company is on the cusp of breaking above the rounding formation, signalling resumption of the upmove and that offers a fresh entry opportunity, Bajaj Broking said. It recommends buying Laurus Labs in the ₹555 – ₹575 range for a price target of ₹710, implying a potential upside of 26% for the next 12 months.
Himadri Specialty Chemicals | Bajaj Broking recommends buying the stock in the ₹525 – ₹545 range for a price target of ₹687, which implies a potential upside of 28% for the next 12 months. The development of first commercial plant with a 40,000 MTPA capacity for LFP Cathode Active Material is progressing as planned and is scheduled to be operational by Q3 FY27, the brokerage said. The stock has also broken above the supply line joining the highs of 2007 and 2018, highlighting strength.
ITD Cementation | The company has a pipeline of around ₹30,000 crore in projects at various stages, with bids for projects between ₹12,000 crore to ₹13,000 crore already submitted. The company expects to win orders worth ₹10,000 crore by the end of the current financial year. The management is also confident of achieving 20% to 25% growth rate in the coming years. Bajaj Broking recommends buying the stock in the ₹498 – ₹518 range for an upside target of ₹670, a potential upside of 32% over the next 12 months.